α-Phellandrene alters expression of genes associated with DNA damage, cell cycle, and apoptosis in murine leukemia WEHI-3 cells

Anticancer Research

Volumn 34, Issue 8, 2014, Pages 4161-4180

  Lin, Jen Jyh ^a,b   Yu, Chien Chih ^a   Lu, Kung Wen ^a   Chang, Shu Jen ^a   Yu, Fu Shun ^a   Liao, Ching Lung ^a   Lin, Jaung Geng ^a   Chung, Jing Gung ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; cDNA microarray; Cell cycle; DNA damage; WEHI 3 leukemia cells; Phellandrene

Indexed keywords

ALPHA PHELLANDRENE; BCL2 MODIFYING FACTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2D; CYCLIN F2; CYCLIN G2; DEATH BOX POLYPEPTIDE 33; DNA DAMAGE INDUCIBLE TRANSCRIPT 4; ENOLASE 2 GAMMA NEURONAL; FLICE INHIBITORY PROTEIN; G PROTEIN COUPLED RECEPTOR 30; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH ARREST SPECIFIC 5; INHIBITOR OF DIFFERENTIATION 2; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 28B; PROTEIN; PROTEIN BNIP3; PROTEIN PHOSPHATASE 1K; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RADICAL S ADENOSYL METHIONINE DOMAIN CONTAINING 2; RNA; SCHLAFEN 5; SOLUTE CARRIER FAMILY 44 MEMBER 1; STEFIN A; STEFIN A1; TATA BINDING PROTEIN; UBIQUITIN SPECIFIC PEPTIDASE 18; UNCLASSIFIED DRUG; UNINDEXED DRUG; XIAP ASSOCIATED FACTOR 1; CCNE2 PROTEIN, MOUSE; CDKN1A PROTEIN, HUMAN; CYCLINE; TERPENE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; DNA DAMAGE; DNA FRAGMENTATION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; LEUKEMIA CELL LINE; MOUSE; MURINE LEUKEMIA; NONHUMAN; NUCLEOTIDE SEQUENCE; RNA EXTRACTION; UNINDEXED SEQUENCE; UPREGULATION; ANIMAL; CDNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; TUMOR CELL LINE; WEHI-3 LEUKEMIA CELLS; Α-PHELLANDRENE;

APOPTOSIS; CDNA MICROARRAY; CELL CYCLE; DNA DAMAGE; WEHI-3 LEUKEMIA CELLS; Α-PHELLANDRENE;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; GENE EXPRESSION REGULATION, LEUKEMIC; MICE; MONOTERPENES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84908666849     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chen X, Zhou M, Ning B, Song H, Yang S and Tang Y: Transfusion-associated HIV infection in pediatric leukemia patients (two case reports). Iran J Pediatr 22: 417-420, 2012.
2. Tiacci E, Pileri S, Orleth A, Pacini R, Tabarrini A, Frenguelli F, Liso A, Diverio D, Lo-Coco F and Falini B: PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Cancer Res 64: 7399-7404, 2004.
3. Dai Z, Xiao W and Jin Y: Inhibition of nm23-H1 gene expression in chronic myelogenous leukemia cells. Oncol Lett 6: 1093-1097, 2013.
4. Bendaoud H, Romdhane M, Souchard JP, Cazaux S and Bouajila J: Chemical composition and anticancer and antioxidant activities of Schinus molle L. and Schinus terebinthifolius Raddi berries essential oils. J Food Sci 75: C466-472, 2010.
5. Cha JD, Jung EK, Kil BS and Lee KY: Chemical composition and antibacterial activity of essential oil from Artemisia feddei. J Microbiol Biotechnol 17: 2061-2065, 2007.
6. Lin JJ, Lin JH, Hsu SC, Weng SW, Huang YP, Tang NY, Lin JG and Chung JG: Alpha-phellandrene promotes immune responses in normal mice through enhancing macrophage phagocytosis and natural killer cell activities. In Vivo 27: 809-814, 2013.
7. Chang Y-M, Velmurugan BK, Kuo W-W, Chen Y-S, Ho T-J, Tsai C-T, Ye C-X, Tsai C-H, Tsai F-J and Huang C-Y: Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells. Bio Medicine 3: 148-152, 2013.
8. Lin CC, Lin JJ, Wu PP, Lu CC, Chiang JH, Kuo CL, Ji BC, Lee MH, Huang AC and Chung JG: Wogonin, a natural and biologically active flavonoid, influences a murine WEHI-3 leukemia model in vivo through enhancing populations of T- and B-cells. In Vivo 27: 733-738, 2013.
9. Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, Davies C, Williams A and Turpaz Y: Alternative splicing and differential gene expression in colon cancer detected by a whole-genome exon array. BMC Genomics 7: 325, 2006.
10. Douglas D, Hsu JH, Hung L, Cooper A, Abdueva D, van Doorninck J, Peng G, Shimada H, Triche TJ and Lawlor ER: BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression. Cancer Res 68: 6507-6515, 2008.
11. Jacobs AT and Marnett LJ: HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J Biol Chem 284: 9176-9183, 2009.
12. Ayala F, Dewar R, Kieran M and Kalluri R: Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 23: 2233-2241, 2009.
13. Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB, Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA and Golub TR: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487: 500-504, 2012.
14. Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R and Settleman J: Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 487: 505-509, 2012.